{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:13:29Z","timestamp":1793391209518,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020956","name":"Merck Healthcare KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.clinthera.2024.03.011","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T12:18:57Z","timestamp":1714393137000},"page":"389-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioequivalence of Related GelShield\u24c7 Sustained-release Formulations of Metformin: A Pooled Pharmacokinetic Analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Axel","family":"Krebs-Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin M.G.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.F. Nogueira","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedh","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3306-5025","authenticated-orcid":false,"given":"Yvonne","family":"Schnaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.clinthera.2024.03.011_bib0001","first-page":"S158","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0002","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"66","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0003","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.clinthera.2024.03.011_bib0004","first-page":"S43","article-title":"Prevention or delay of diabetes and associated comorbidities: Standards of Care in Diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0005","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0006","unstructured":"Mousa A, Tay CT, Teede H. Technical report for the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. doi 10.26180\/23625288.v1."},{"key":"10.1016\/j.clinthera.2024.03.011_bib0007","first-page":"e49","article-title":"Practice bulletin: clinical management guidelines for obstetricians\u2014gynecologists. gestational diabetes mellitus","volume":"131","year":"2018","journal-title":"Practice Bulletin"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0008","series-title":"Merck","article-title":"Glucophage: Serving diabetology for 40 years","year":"1997"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0009","unstructured":"Lipha 1994 NDA (New Drug Application) 20-357 for Metformin HCl (500 & 850 mg tablets Glucophage, dated July 13, 1994. Accessed and downloaded October 17, 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/pre96\/020357Orig1s000rev.pdf."},{"key":"10.1016\/j.clinthera.2024.03.011_bib0010","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/14746514040040041101","article-title":"New prolonged-release metformin improves gastrointestinal tolerability","volume":"4","author":"Davidson","year":"2004","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0012","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/dom.13104","article-title":"Metformin extended-release versus immediate-release: an international, ranodmized, double-blind, head-to-head trial in pharnacotherapy-na\u00efve patients with type 2 diabetes","volume":"20","author":"Aggarwal","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/dom.13190","article-title":"Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-na\u00efve Chinese patients: analysis of results from the CONSENT trial","volume":"20","author":"Ji","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0014","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nature Rev Endocrinol"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1185\/030079904125003278","article-title":"Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospectuve cohort study","volume":"20","author":"Blonde","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0016","unstructured":"NICE (National Institute for Health and Care Excellence) Guideline: type 2 diabetes in adults: management. Accessed October 17, 2023. https:\/\/www.nice.org.uk\/guidance\/ng28."},{"key":"10.1016\/j.clinthera.2024.03.011_bib0017","unstructured":"EMC (Electronic Medicines Compendium). Glucophage SR 500 mg prolonged release tablets. Revision of SmPC 13-03-2015. Accessed November 20, 2023. https:\/\/www.medicines.org.uk\/emc\/product\/10723\/smpc\/history."},{"key":"10.1016\/j.clinthera.2024.03.011_bib0018","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1463-1326.2004.00369.x","volume":"7","author":"Fujioka","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0019","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/cpdd.1158","article-title":"Bioequivalence of China- and Germany-manufactured metformin extended-release tablets under fed and fasted conditions in healthy volunteers: a randomized, open-label, 2-way crossover study","volume":"11","author":"Hu","year":"2022","journal-title":"Clin Pharmacol Drug Devlopment"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0020","unstructured":"FDA (Food and Drug Administration). Statistical approaches to establishing bioequivalence: guidance for industry. Accessed January 26, 2024. https:\/\/www.fda.gov\/media\/70958\/download."},{"key":"10.1016\/j.clinthera.2024.03.011_bib0021","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00228-012-1396-1","article-title":"Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether\/lumefantrine 20\/120 mg tablets as prequalified by WHO","volume":"68","author":"Gwaza","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0022","unstructured":"FDA (Food and Drug Administration). Bioavailability studies submitted in NDAs or INDs: general considerations\u2014guidance for industry. Accessed November 17, 2023. https:\/\/www.fda.gov\/media\/121311\/download."},{"key":"10.1016\/j.clinthera.2024.03.011_bib0023","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/dom.13264","article-title":"Pharmacokinetics of metformin in patients with gastrointestinal tolerance","volume":"20","author":"McCreight","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2024.03.011_bib0024","series-title":"International Diabetes Federation (IDF) Congress","article-title":"Pooled pharmacokinetic bioequivalence analysis of metformin sustained release formulations","author":"Krebs-Brown","year":"2022"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:39:46Z","timestamp":1719531586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0149291824000778"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.03.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioequivalence of Related GelShield\u24c7 Sustained-release Formulations of Metformin: A Pooled Pharmacokinetic Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}